+44 (0)114 215 9667 mellanbycentre@sheffield.ac.uk

Publications

Professor Richard Eastell

Eastell, R., Dijk, D.J., Small, M., Greenwood, A., Sharpe, J., Yamada, H., Yuba, M., Tanimoto, M. & Deacon, S. (2015) Morning vs evening dosing of the cathepsin K inhibitor ONO-533: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial. Osteoporos Int. Oct 7. [Epub ahead of print] PubMed PMID: 26446770

Blum, M.R., Bauer, D.C., Collet, T.H., Fink, H.A., Cappola, A.R., da Costa, B.R., Wirth, C.D., Peeters, R.P., Åsvold, B.O., den Elzen, W.P., Luben, R.N., Imaizumi, M., Bremner, A.P., Gogakos, A., Eastell, R., Kearney, P.M., Strotmeyer, E.S., Wallace, E.R., Hoff, M., Ceresini, G., Rivadeneira, F., Uitterlinden, A.G., Stott, D.J., Westendorp, R.G., Khaw, K.T., Langhammer, A., Ferrucci, L., Gussekloo, J., Williams, G.R., Walsh, J.P., Jüni, P., Aujesky, D., Rodondi, N. (2015) Thyroid Studies Collaboration. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 26;313(20):2055-65. doi: 10.1001/jama.2015.5161.
PubMed PMID: 26010634

Naylor, K.E., Jacques, R.M., Paggiosi, M., Gossiel, F., Peel, N.F., McCloskey, E.V., Walsh, J.S., Eastell, R. (2015) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int May 20. [Epub ahead of print] PubMed PMID: 25990354

Paggiosi, M.A., Peel, N.F., Eastell, R. (2015) The impact of glucocorticoid therapy on trabecular bone score in older women. Osteoporos Int Jun;26(6):1773-80 doi: 10.1007/s00198-015-3078-1. Epub 2015 Mar 6. PubMed PMID: 25743176

Palermo, A., Jacques, R., Gossiel, F., Reid, D.M., Roux, C., Felsenberg, D., Glueer, C.C., Eastell, R. (2015) Normocalcaemic hypoparathyroidism: prevalence and effect on bone status in older women. The OPUS study. Clin Endocrinol (Oxf. Jun;82(6):816-23. doi: 10.1111/cen.12732. Epub 2015 Feb 23. PubMed PMID: 25640980

Black, D.M., Reid, I.R., Cauley, J.A., Cosman, F., Leung, P.C., Lakatos, P., Lippuner, K., Cummings, S.R., Hue, T.F., Mukhopadhyay, A., Tan, M., Aftring, R.P., Eastell, R. (2015) The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res May;30(5):934-44. doi: 10.1002/jbmr.2442. PubMed PMID: 25545380

Dimitri, P., Jacques, R.M., Paggiosi, M., King, D., Walsh, J., Taylor, Z.A., Frangi, A.F., Bishop, N., Eastell, R. (2015) Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab Feb;100(2):594-602. doi:10.1210/jc.2014-3199. Epub 2014 Nov 20. PubMed PMID: 25412414; PubMed Central PMCID: PMC4318898

Evans, A.L., Paggiosi, M.A., Eastell, R., Walsh, J.S. (2015) Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res May;30(5):920-8. doi: 10.1002/jbmr.2407. PubMed PMID: 25400253

Eastell, R., Boonen, S., Cosman, F., Reid, I.R., Palermo, L., Cummings, S.R., Black, D.M. (2015) Relationship between pre-treatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J Bone Miner Res Mar;30(3):570-4. doi: 10.1002/jbmr.2361. PubMed PMID: 25214069

Palermo, A., D’Onofrio, L., Eastell, R., Schwartz, A.V., Pozzilli, P., Napoli, N. (2015) Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review. Osteoporos Int Aug;26(8):2073-89. doi: 10.1007/s00198-015-3123-0. Epub 2015 Apr 25. PubMed PMID: 25910746